ABOUT

History

DR.NOAH Biotech has been around since its inception in January 2017.
We're constantly working on new drugs.

2017.01
~ Now

    2022

  • DECApplication for PCT of Pharmaceutical Composition for the Treatment of Brain Diseases.
    VasThera Consignment Research Contract.
    NDC-002 (Stroke Recovery) Recruitment of Phase 1 Trial Patients in Korea.
  • AUGNeuroRG Patent Registration (Korea).
  • JULNeuroRG PCT Application.
  • MAYSeries B Investment completed (Gradiant, CKD, L&S, Yuantainvestment, and more).
  • APRNDC-002 (Stroke Recovery) Approved IND for Phase 1 Clinical Trial by MFDS (Korea).
  • FEBLaunching AI platform technology business (NeuroRG).
  • JANPatent application for candidate materials for SK Chemicals joint R&D (3 cases).

    2021

  • DECJoint Research Contract Amorepacific, Registers CombiRisk Patent (Korea).
  • AUGNeuroRG Patent Application
  • JULNDC-002 (Stroke Recovery) Submission of Phase 1 clinical IND of MFDS (Korea).
  • MARJoint Research Contract with Amorepacific.

    2020